Medicare Rx Plan Price Reviews By CMS Are “Appropriate,” MedPAC Says
Executive Summary
The Centers for Medicare & Medicaid Services' proposal to review Medicare prescription drug prices when negotiating plan bids is "appropriate," the Medicare Payment Advisory Commission said